Health
Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone – Medical Xpress
Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had…
Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival, according to results of a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
“Dexamethasone is a potent corticosteroid that is often prescribed to patients with glioblastoma to treat symptoms related to cerebral edema, or swelling in the brain,” said…
-
General22 hours agoHow they started and how they finished • Inside Story
-
Noosa News22 hours agoAustralian farmers express ‘profound disappointment’ as tariffs on Aussie beef backfires on Americans
-
Business21 hours agoWhich ASX sectors led the pack in March, according to Macquarie?
-
Noosa News24 hours agoHonour awarded at cocktail party – Proctor